Rapid responses are electronic comments to the editor. They enable our users to debate issues raised in articles published on bmj.com. A rapid response is first posted online. If you need the URL (web address) of an individual response, simply click on the response headline and copy the URL from the browser window. A proportion of responses will, after editing, be published online and in the print journal as letters, which are indexed in PubMed. Rapid responses are not indexed in PubMed and they are not journal articles. The BMJ reserves the right to remove responses which are being wilfully misrepresented as published articles.
It has been brought to my attention that a rapid response has been posted to the original study by Deeks et al clarifying that the app named “SkinScan” in the Chadwick et al 2014 study is not related to the current “skinScan” app produced by TeleSkin (https://teleskin.org/) as they infer in the paper, and as I reference in the editorial.
The authors explain: “ It appears that there was more than one app using the name SkinScan at the point in time when the study was done. Chadwick et al indicate that the version of the “SkinScan” app they evaluated later became SkinVision. Thus we now believe that the data we described as relating to SkinScan would better be described as being for the an early version of the SkinVision app. We apologise to Teleskin for this error.”